Yashoda Medicity Strengthens Organ Transplant Ecosystem with DGME-Approved Brain Stem Death Certification Committee

The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants.

Delhi NCR 08th June 2026: In a significant development for organ donation and transplantation services in the state, Yashoda Medicity, one of the leading hospitals in Delhi-NCR has received formal approval from the Directorate General of Medical Education (DGME), Uttar Pradesh, for the constitution of its Brain Stem Death Certification Committee.

The approval authorizes Yashoda Medicity to conduct and certify Brain Stem Death assessments in accordance with the Transplantation of Human Organs and Tissues Act (THOTA) and prescribed medical and legal protocols. It establishes a structured and compliant pathway for deceased organ donation, an essential component of modern transplant programmes.

As demand for organ transplantation continues to rise across India, the approval enhances the hospital’s ability to support deceased donor programmes and facilitate organ donation processes in accordance with established legal and ethical standards.

Dr. P.N. Arora, Chairman and Managing Director, Yashoda Medicity, said, “Every successful organ transplant begins long before the surgery itself; it begins with systems that ensure clinical certainty, ethical integrity, and public trust. The constitution of the Brain Stem Death Certification Committee creates that foundation. As India seeks to bridge the gap between organ demand and availability, strengthening institutional mechanisms for deceased organ donation becomes essential. This approval enables us to contribute more meaningfully to a process that has the potential to save multiple lives through a single act of donation.”

The committee brings together specialists across disciplines to ensure timely and standardized certification of brain stem death cases, while supporting regulatory compliance. It will also facilitate coordinated decision-making among critical care teams, transplant specialists, counsellors, and clinical administrators involved in the organ donation pathway.

The approval further strengthens Yashoda Medicity’s clinical governance framework and reflects its commitment to the highest standards of medical, ethical, and regulatory practice. It also reinforces the hospital’s growing capabilities in critical care and transplantation, supporting better long-term outcomes for patients requiring advanced treatment.

Dr. R.K. Mani, Director, Clinical Services (40+ years of experience in Critical care, Respiratory & Sleep Medicine) Yashoda Medicity, said, “Brain stem death certification is one of the most important functions in critical care practice. It has crucial links with the deceased organ donation pathway combining medical science, legal norms, and ethical requirements. Robust frameworks such as this help ensure consistency and transparency while creating greater opportunities for patients waiting for life-saving transplants. Equally important, they help build public understanding of organ donation and reinforce confidence in the processes that make organ retrieval for transplantation possible.”

Check Also

S8UL’s Apex Legends team qualifies for Esports World Cup 2026

Following qualifications in Chess, Fortnite, and Honor of Kings, Apex Legends becomes the fourth title …

toto slot